Carol S. Surowy

2.2k total citations
51 papers, 1.6k citations indexed

About

Carol S. Surowy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Carol S. Surowy has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 12 papers in Physiology. Recurrent topics in Carol S. Surowy's work include Nicotinic Acetylcholine Receptors Study (15 papers), Ion channel regulation and function (13 papers) and Pain Mechanisms and Treatments (12 papers). Carol S. Surowy is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (15 papers), Ion channel regulation and function (13 papers) and Pain Mechanisms and Treatments (12 papers). Carol S. Surowy collaborates with scholars based in United States, United Kingdom and Germany. Carol S. Surowy's co-authors include Richard A. Spritz, Connie R. Faltynek, Nathan A. Berger, Pamela S. Puttfarcken, Michael F. Jarvis, Prisca Honoré, Ying‐Jun Cao, Kathleen M. Strunk, Vicky L. van Santen and Torben R. Neelands and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Carol S. Surowy

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol S. Surowy United States	27	859	328	263	263	239	51	1.6k
Grazia Chiellini Italy	22	834 1.0×	338 1.0×	97 0.4×	290 1.1×	89 0.4×	47	1.8k
Philip Wahl Denmark	21	672 0.8×	417 1.3×	205 0.8×	193 0.7×	91 0.4×	44	1.3k
Sui‐Po Zhang United States	19	537 0.6×	416 1.3×	141 0.5×	177 0.7×	119 0.5×	45	976
Francisco Javier Martı́n-Romero Spain	25	667 0.8×	302 0.9×	329 1.3×	244 0.9×	65 0.3×	45	1.6k
Laura Rauser United States	10	552 0.6×	433 1.3×	43 0.2×	158 0.6×	226 0.9×	11	1.4k
Jaime M. Merino Spain	18	636 0.7×	197 0.6×	180 0.7×	160 0.6×	66 0.3×	41	1.2k
Sonya G. Lehto United States	20	494 0.6×	455 1.4×	623 2.4×	470 1.8×	70 0.3×	28	1.5k
Ian C. B. Marshall United Kingdom	16	695 0.8×	177 0.5×	390 1.5×	162 0.6×	28 0.1×	21	1.2k
Takuma Shiraki Japan	18	824 1.0×	161 0.5×	72 0.3×	317 1.2×	309 1.3×	33	1.5k
Minori Mitsui‐Saito Japan	10	638 0.7×	206 0.6×	91 0.3×	398 1.5×	61 0.3×	21	1.2k

Countries citing papers authored by Carol S. Surowy

Since Specialization

Citations

This map shows the geographic impact of Carol S. Surowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol S. Surowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol S. Surowy more than expected).

Fields of papers citing papers by Carol S. Surowy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol S. Surowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol S. Surowy. The network helps show where Carol S. Surowy may publish in the future.

Co-authorship network of co-authors of Carol S. Surowy

This figure shows the co-authorship network connecting the top 25 collaborators of Carol S. Surowy. A scholar is included among the top collaborators of Carol S. Surowy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol S. Surowy. Carol S. Surowy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xufeng, Di Zhang, Carol S. Surowy, et al.. (2012). Development and Validation of a Medium-Throughput Electrophysiological Assay for KCNQ2/3 Channel Openers Using QPatch HT. Assay and Drug Development Technologies. 11(1). 17–24. 2 indexed citations

Schrimpf, Michael R., Clark A. Briggs, David J. Anderson, et al.. (2012). SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore. Bioorganic & Medicinal Chemistry Letters. 22(4). 1633–1638. 26 indexed citations

Zhang, Xufeng, Ping Han, Torben R. Neelands, et al.. (2011). Coexpression and activation of TRPV1 suppress the activity of the KCNQ2/3 channel. The Journal of General Physiology. 138(3). 341–352. 20 indexed citations

Zhang, Di, Rama Thimmapaya, Xu‐Feng Zhang, et al.. (2011). KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels. Journal of Neuroscience Methods. 200(1). 54–62. 9 indexed citations

Vortherms, Timothy A., Andrew M. Swensen, Wende Niforatos, et al.. (2011). Comparative analysis of inactivated-state block of N-type (Cav2.2) calcium channels. Inflammation Research. 60(7). 683–693. 5 indexed citations

Davis‐Taber, Rachel, Scott Baker, Sonya G. Lehto, et al.. (2008). Central Pituitary Adenylate Cyclase 1 Receptors Modulate Nociceptive Behaviors in Both Inflammatory and Neuropathic Pain States. Journal of Pain. 9(5). 449–456. 36 indexed citations

Anderson, David J., William H. Bunnelle, Bruce W. Surber, et al.. (2007). [3H]A-585539 [(1 S,4 S)-2,2-Dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a Novel High-Affinity α7 Neuronal Nicotinic Receptor Agonist: Radioligand Binding Characterization to Rat and Human Brain. Journal of Pharmacology and Experimental Therapeutics. 324(1). 179–187. 46 indexed citations

Gomtsyan, Arthur, Erol K. Bayburt, Ryan G. Keddy, et al.. (2007). α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model. Bioorganic & Medicinal Chemistry Letters. 17(14). 3894–3899. 26 indexed citations

Bianchi, Bruce R., Rachid El Kouhen, Torben R. Neelands, et al.. (2007). [3H]A-778317 [1-((R)-5-tert-Butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a Novel, Stereoselective, High-Affinity Antagonist Is a Useful Radioligand for the Human Transient Receptor Potential Vanilloid-1 (TRPV1) Receptor. Journal of Pharmacology and Experimental Therapeutics. 323(1). 285–293. 12 indexed citations

10.

Ji, Jianguo, Michael R. Schrimpf, William H. Bunnelle, et al.. (2007). Synthesis and Structure−Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists. Journal of Medicinal Chemistry. 50(22). 5493–5508. 40 indexed citations

11.

Kouhen, Rachid El, Carol S. Surowy, Bruce R. Bianchi, et al.. (2005). A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel and Selective Transient Receptor Potential Type V1 Receptor Antagonist, Blocks Channel Activation by Vanilloids, Heat, and Acid. Journal of Pharmacology and Experimental Therapeutics. 314(1). 400–409. 90 indexed citations

12.

Thimmapaya, Rama, Torben R. Neelands, Wende Niforatos, et al.. (2005). Distribution and functional characterization of human Nav1.3 splice variants.. PubMed. 22(1). 1–9. 6 indexed citations

13.

Cao, Ying‐Jun, Carol S. Surowy, & Pamela S. Puttfarcken. (2005). Nicotinic Acetylcholine Receptor-Mediated ( 3 H)Dopamine Release from Hippocampus. 2 indexed citations

14.

Thimmapaya, Rama, Torben R. Neelands, Wende Niforatos, et al.. (2005). Distribution and functional characterization of human Na_v1.3 splice variants. European Journal of Neuroscience. 22(1). 1–9. 27 indexed citations

15.

Neelands, Torben R., Connie R. Faltynek, & Carol S. Surowy. (2004). Receptors and channels. Journal of Pain. 5(3). S10–S10.

16.

Rueter, Lynne E., Kathy L. Kohlhaas, Peter Curzon, Carol S. Surowy, & Michael D. Meyer. (2003). Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain. Pain. 103(3). 269–276. 32 indexed citations

17.

Smith, Morey L., Stephen J. Ballaron, Michael P. Sheets, et al.. (2002). TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators. Cellular Immunology. 220(2). 134–142. 27 indexed citations

18.

Baine, Yaela, Paul D. Miller, Cheryl A. Hobbs, et al.. (1995). Functional characterization of novel IL-2 transcriptional inhibitors.. The Journal of Immunology. 154(8). 3667–3677. 7 indexed citations

19.

Spritz, Richard A., Kathleen M. Strunk, Carol S. Surowy, & Harvey W. Mohrenweiser. (1990). Human U1-70K ribonucleoprotein antigen gene: Organization, nucleotide sequence, and mapping to locus 19q13.3. Genomics. 8(2). 371–379. 13 indexed citations

20.

Surowy, Carol S. & Nathan A. Berger. (1985). A 3-aminobenzamide-resistant labeled protein in [32P]NAD+-labeled cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 847(3). 309–315. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact